肉中的含量及其对厄瓜多尔消费者的健康风险评估
Gabriela S Yánez-Jácome1, David Romero-Estévez1, Ana P Rosero-Jácome2
1Centro de Estudios Aplicados en Química, Pontificia Universidad Católica del Ecuador, Av. 12 de Octubre 1076 y Roca, Quito, Pichincha 170525, Ecuador.
概括
肉中的污染构成风险,特别是在地面品种中. 这项研究发现,厄瓜多尔肉的含量过高,超过了监管限制,这表明了消费者潜在的健康问题.
科学领域:
- 食品安全 食品安全
- 环境毒理学环境毒理学
- 分析化学 分析化学
背景情况:
- (Pb) 是一种有毒的金属,影响人类健康,特别是神经系统.
- 诸如肉之类的香料被认为是人类暴露的潜在途径.
- 美国2023年10月的一项安全警报强调了儿童摄入受污染的果肉粉中血含量升高的情况.
研究的目的:
- 为了量化埃瓜多尔销售的碎和粘样品中的含量.
- 评估是否符合厄瓜多尔和欧盟法规规定的最高含量.
- 评估与肉消费相关的潜在非致癌和致癌健康风险.
主要方法:
- 分析了来自厄瓜多尔各个品牌和批量的61个碎和粘肉样本.
- 使用[在摘要中未提及的特定分析技术]测量 (Pb) 含量.
- 统计分析 (克鲁斯卡尔-瓦利斯测试) 用于比较肉类型之间的含量,并评估显著性 (p < 0.05).
主要成果:
- 与棒肉 (0.36 ± 0.28 mg/kg) 相比,地面肉样本的含量显著更高 (0.80 ± 0.75 mg/kg).
- 三个碎肉样本超过了厄瓜多尔和欧盟法规规定的允许的最大限值 (2.0 mg/kg).
- 虽然非致癌风险 (HQ值) 是可以忽略不计的,但在平均度和最大度下,已确定地肉的致癌风险.
结论:
- 厄瓜多尔肉,特别是地面品种,显示出有关污染的水平.
- 现有的食品安全监督系统和食品金属国家法规需要加强.
- 消费者,特别是儿童,可能面临通过污染的肉产品暴露于的健康风险.
相关概念视频
Prevention of Further Absorption of Poison
795
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
795
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Pharmacovigilance
786
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
786
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Bioavailability: Overview
2.7K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.7K
Levels of Health Promotion and Illness Prevention
12.5K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
In primary prevention, actions taken before disease onset prevent the disease from...
12.5K


